Skip to Content

Clofarabine Pregnancy and Breastfeeding Warnings

Clofarabine is also known as: Clolar

Clofarabine Pregnancy Warnings

Clofarabine has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of teratogenicity, developmental toxicity (reduced fetal body weight and increased postimplantation loss) and increased incidences of malformations and variations (gross external, soft tissue, skeletal, and retarded ossification). There are no controlled data in human pregnancy. Clofarabine should only be given during pregnancy when there are no alternatives and benefit outweighs risk.

Women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with clofarabine. Animal studies have reported adverse effects on male reproductive organs including seminiferous tubule and testicular degeneration and atrophy. Bilateral degeneration of the seminiferous epithelium with retained spermatids and atrophy of interstitial cells have also been reported in animal studies. Ovarian atrophy or degeneration and uterine mucosal apoptosis have been reported in female animal studies.

See references

Clofarabine Breastfeeding Warnings

There are no data on the excretion of clofarabine or its metabolites into human milk. The manufacturer has stated that female patients should be advised to avoid breast-feeding during treatment with clofarabine.

See references

References for pregnancy information

  1. "Product Information. Clolar (clofarabine)." Genzyme Corporation, Cambridge, MA.

References for breastfeeding information

  1. "Product Information. Clolar (clofarabine)." Genzyme Corporation, Cambridge, MA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.